NeuroPace Inc
Develops an FDA-approved brain-responsive neurostimulation system for epilepsy.
NPCE | US
Overview
Corporate Details
- ISIN(s):
- US6412881053
- LEI:
- Country:
- United States of America
- Address:
- 455 N. BERNARDO AVENUE, 94043 MOUNTAIN VIEW
- Website:
- https://www.neuropace.com/
- Sector:
- Manufacturing
Description
NeuroPace Inc. is a commercial-stage medical device company focused on the treatment of neurological disorders. The company designs, develops, and markets implantable devices that utilize responsive neurostimulation. Its flagship product, the RNS® System, is the only FDA-approved brain-responsive neurostimulation system for adults with drug-resistant focal epilepsy. The RNS System continuously monitors brain activity, detects patient-specific abnormal electrical patterns, and delivers personalized electrical stimulation in real-time to prevent seizures at their source. In addition to providing therapeutic stimulation, the device also records and provides physicians with long-term electroencephalographic (EEG) data to help optimize patient care and treatment plans.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NeuroPace Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NeuroPace Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NeuroPace Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
